The chylomicron saga: time to focus on postprandial metabolism

Overview of attention for article published in Frontiers in endocrinology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,993 followers.

RT @Malnutridos: "El éxito de las estatinas ha propiciado el enfoque en las LDL. Pero el 50% de los pacientes que toman estatinas siguen e…

14 Feb 2024

Reply Repost Favourite

"El éxito de las estatinas ha propiciado el enfoque en las LDL. Pero el 50% de los pacientes que toman estatinas siguen en riesgo cardiovascular. El riesgo residual se atribuye en parte a las lipoproteínas ricas en triglicéridos (TRL) y sus remanentes."

14 Feb 2024

Reply Repost Favourite

The chylomicron saga: time to focus on postprandial metabolism Alejandro Gugliucci. Front Endocrinol (Lausanne). 2024. https://t.co/tJ9l5CQRsj

08 Feb 2024

Reply Repost Favourite

New Research: The chylomicron saga: time to focus on postprandial metabolism: Since statins have had such tremendous therapeutic success over the last three decades, the field of atherosclerosis has become somewhat LDL-centric,… https://t.co/s9rTZHvdFU #En

18 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.